# Sodium Bicarbonate Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current, To Be Discontinued - FDA package records: 19 - Latest FDA row update: 11/07/2025 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Amphastar Pharmaceuticals, Inc. — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) — FDA availability: Limited Availability — updated: 08/18/2026 - Exela Pharma Sciences, LLC — Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) — FDA availability: Available — updated: 07/22/2026 - Exela Pharma Sciences, LLC — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) — FDA availability: Available — updated: 07/22/2026 - Exela Pharma Sciences, LLC — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) — FDA availability: Available — updated: 07/22/2026 - Fresenius Kabi USA, LLC — Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) — FDA availability: Available — updated: 08/04/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14) — FDA availability: Not stated — updated: 11/07/2025 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14) — FDA availability: Not stated — updated: 11/07/2025 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-4900-14) — FDA availability: Not stated — updated: 11/07/2025 - Hospira, Inc., a Pfizer Company — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14) — FDA availability: Not stated — updated: 11/07/2025 - Long Grove Pharmaceuticals LLC — Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) — FDA availability: Available — updated: 08/17/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/sodium-bicarbonate-injection) - [JSON record](https://citefacts.com/shortages/sodium-bicarbonate-injection.json)